Rubicon Research Ltd.

Financial

	Rubicon Research	Bal Pharma	Natural Capsules
Operational Metrics
Financials
5 yr Average ROE	3.69 %	1.96 %	9.36 %
5yr average Equity Multiplier	2.01	4.59	1.81
5yr Average Asset Turnover Ratio	0.61	0.98	0.69
5yr Avg Net Profit Margin	2.7 %	-0.04 %	6.89 %
Price to Book	n/a	2.2	0.91
P/E	n/a	20.81	200.17
5yr Avg Cash Conversion Cycle	20.92 Days	41.77 Days	23.72 Days
Inventory Days	81.01 Days	106.16 Days	23.56 Days
Days Receivable	112.52 Days	104.16 Days	125.17 Days
Days Payable	213.42 Days	132.37 Days	108.82 Days
5yr Average Interest Coverage Ratio	3.92	1.22	8.18
5yr Avg ROCE	10.39 %	15.4 %	10.24 %
5yr Avg Operating Profit Margin	15.74 %	7.79 %	14.58 %
5 yr average Debt to Equity	0.61	2.03	0.44
5yr CAGR Net Profit	12.99 %	n/a	45.2 %
5yr Average Return on Assets	2.24 %	0.43 %	4.88 %
Shareholdings
Promoter Holding	n/a	50.86 %	51.21 %
Share Pledged by Promoters	n/a	0.0	0.0
Change in Promoter Holding (3 Yrs)	n/a	1.29 %	-5.36 %
Change in Mutual Fund Holding (3 Yrs)	n/a	0.0	0.0